Skip to main content

Table 2 Intra- and cross-platform comparison of DEG lists generated from simulated microarray and RNA-Seq data.

From: Parallel comparison of Illumina RNA-Seq and Affymetrix microarray platforms on transcriptomic profiles generated from 5-aza-deoxy-cytidine treated HT-29 colon cancer cells and simulated datasets

 

T-test

Ebayes

SAM

baySeq

DESeq

SAMseq

NOISeq

T-test

100.0%

      

Ebayes

5.1%

100.0%

     

SAM

4.8%

95.1%

100.0%

    

baySeq

3.0%

48.1%

49.6%

100.0%

   

DESeq

3.3%

48.7%

50.2%

75.7%

100.0%

  

SAMseq

3.4%

36.5%

37.0%

54.1%

51.9%

100.0%

 

NOISeq

3.3%

39.7%

39.7%

46.5%

50.4%

46.9%

100%

  1. The simulations were carried out as described in Methods. The overlap percentages was calculated based on the percent of true positive DEGs (95% minimum fold change method: FC ≥ 2 & FDR < = 0.05) identified by each of the three microarray algorithms (T-test, SAM, eBayes) and four RNA-Seq algorithms (SAMseq, baySeq, DESeq, NOISeq).
  2. ¹The overlap rate was calculated based on true positive DEGs called by each method. The microarray and RNA-Seq cross-platform DEG overlap rates are shown in bold style.